Track the PNV stock price and the full directors' dealings record of the company, a listed issuer based in Australia. Shares are quoted on the AU market, under the authority of ASX. Operating in the Health Care sector, PNV has recorded 8 insider filings. Market capitalisation: €666.7m. The latest transaction was filed on 23 August 2026 (Cease Substantial Holding). Among the most active insiders: 2. Changes in relevant interests. All data is openly available.
8
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate PNV Buy (bullish), based on 8 analysts. Average price target: A$1.46.
Fundamental score
Ranked 12,334 of 28,822 companies
55.7
score / 100
Value
38
Quality
73
FCF yld-1.5%
Earn yld1.8%
EV/EBITDA·
ROE12%
Gross mgn96%
Net mgn10%
Debt/EBITDA1.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
PNV is a company operating in the healthcare and pharmaceutical sector, listed on the XASX market. It focuses on developing innovative solutions to enhance healthcare.